_life-sciences-data-management-and-compliance.jpg "Life Sciences Data Management and Compliance from cfr biotechnology Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 71 sec
✓ Published: 17-Jun-2021
✓ Published: 17-Jun-2021
Description:
Egnyte for Life Sciences helps leading biotechnology, medical device, and drug development companies innovate faster through seamless compliance and unified document management. This overview video showcases how Egnyte's data privacy, GxP compliance, audit, eTMF, workflow, and Quality documentation products help Life Sciences companies connect globally distributed teams and protect their content. nnEgnyte's security and governance features enable secure remote work and empower clinicians, lab re
Egnyte for Life Sciences helps leading biotechnology, medical device, and drug development companies innovate faster through seamless compliance and unified document management. This overview video showcases how Egnyte's data privacy, GxP compliance, audit, eTMF, workflow, and Quality documentation products help Life Sciences companies connect globally distributed teams and protect their content. nnEgnyte's security and governance features enable secure remote work and empower clinicians, lab re
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_fda39s-current-thinking-on-cgmp-compliance-for-phase-i-investigational-drug-and-biologic-products.webp "GlobalCompliance Panel")
⏲ 39 minutes 23 seconds 👁 1.2K
_21-cfr-parts-210-and-211.webp "Compliance Insight")
_chapter-three-biotechnology-part-2.webp "Science for all exams SST SPSC STS IBA NTS PTS OTS FPSC.")
_cmc-considerations-for-biotechnology-product-development-a-regulatory-perspective.webp "U.S. Food and Drug Administration")
⏲ 56 minutes 24 seconds 👁 6.6K
_fda39s-current-thinking-on-cgmp-compliance-for-phase-i-investigational-drug-and-biologic-products.jpg)
_21-cfr-parts-210-and-211.jpg)
_chapter-three-biotechnology-part-2.jpg)
_cmc-considerations-for-biotechnology-product-development-a-regulatory-perspective.jpg)
![[+]](/images/menu.gif){kind=small}